[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608979":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":260,"collaborators":25,"id":262,"slug":263,"hasResults":264,"nctId":265,"briefTitle":266,"officialTitle":267,"acronym":25,"eligibilityCriteria":268,"healthyVolunteers":264,"sex":269,"minAge":270,"maxAge":271,"enrollmentInfo":272,"targetDuration":25,"studyType":275,"phases":276,"briefSummary":278,"conditions":279,"keywords":25,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":281,"lastUpdatePostDateStruct":282,"startDateStruct":285,"completionDateStruct":287,"leadSponsor":289,"locationsCount":290},{"fullName":5,"class":6},"Staidson (Beijing) Biopharmaceuticals Co., Ltd","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental group","EXPERIMENTAL","Patients in this group will receive basal treatment and STSA-1002.",[13],"Drug: STSA-1002 injection",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo group","PLACEBO_COMPARATOR",[18],"Drug: STSA-1002 Injection Placebo",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","STSA-1002 injection","basal treatment + STASA-1002 intravenous infusion",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"STSA-1002 Injection Placebo","basal treatment + STSA-1002 Injection Placebo",[15],[31],{"name":32,"affiliation":33,"role":34},"Bin M.D. Cao","China-Japan Friendship Hospital","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},"Aiping Sun","CONTACT","+8618611103198","sunaiping@staidson.com",[42,60,75,90,101,116,131,145,156,171,186,201,216,231,245],{"facility":33,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Beijing","Beijing Municipality","100029","China","CN",{"type":50,"coordinates":51},"Point",[52,53],116.39723,39.9075,{"lat":53,"lon":52},[56],{"name":57,"role":38,"phone":58,"phoneExt":25,"email":59},"Bin Cao","13911318339","caobin_ben@163.com",{"facility":61,"status":43,"city":62,"state":63,"zip":64,"country":47,"countryCode":48,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"The First Affiliated Hospital of Xiamen University","Xiamen","Fujian","361003",{"type":50,"coordinates":66},[67,68],118.08187,24.47979,{"lat":68,"lon":67},[71],{"name":72,"role":38,"phone":73,"phoneExt":25,"email":74},"Yihua Lin","13515968915","yhlin_xm@163.com",{"facility":76,"status":43,"city":77,"state":78,"zip":79,"country":47,"countryCode":48,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"The Third Affiliated Hospital of Guangzhou Medical University","Guangzhou","Guangdong","510150",{"type":50,"coordinates":81},[82,83],113.25,23.11667,{"lat":83,"lon":82},[86],{"name":87,"role":38,"phone":88,"phoneExt":25,"email":89},"Yichun Wang","18127945241","wangyichun2005@163.com",{"facility":91,"status":43,"city":77,"state":78,"zip":92,"country":47,"countryCode":48,"cosmosGeoPoint":93,"geoPoint":95,"contacts":96},"The First Affiliated Hospital, Sun Yat-sen University","51063",{"type":50,"coordinates":94},[82,83],{"lat":83,"lon":82},[97],{"name":98,"role":38,"phone":99,"phoneExt":25,"email":100},"Yifeng Luo","13760796562","13760796562@163.com",{"facility":102,"status":43,"city":103,"state":104,"zip":105,"country":47,"countryCode":48,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"The Affiliated Hospital of Zunyi Medical University","Zunyi","Guizhou","563000",{"type":50,"coordinates":107},[108,109],106.90722,27.68667,{"lat":109,"lon":108},[112],{"name":113,"role":38,"phone":114,"phoneExt":25,"email":115},"Tao Chen","15329112288","2395086838@qq.com",{"facility":117,"status":43,"city":118,"state":119,"zip":120,"country":47,"countryCode":48,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"The First Affiliated Hospital of Henan University of Science and Technology","Luoyang","Henan","471099",{"type":50,"coordinates":122},[123,124],112.43684,34.67345,{"lat":124,"lon":123},[127],{"name":128,"role":38,"phone":129,"phoneExt":25,"email":130},"Yongmei Zhang","13683861918","zzyymm666@sina.com",{"facility":132,"status":43,"city":133,"state":119,"zip":134,"country":47,"countryCode":48,"cosmosGeoPoint":135,"geoPoint":139,"contacts":140},"Henan Provincial People's Hospital","Zhengzhou","450003",{"type":50,"coordinates":136},[137,138],113.64861,34.75778,{"lat":138,"lon":137},[141],{"name":142,"role":38,"phone":143,"phoneExt":25,"email":144},"Xiaoju Zhang","15837101166","15837101166@163.com",{"facility":146,"status":43,"city":133,"state":119,"zip":147,"country":47,"countryCode":48,"cosmosGeoPoint":148,"geoPoint":150,"contacts":151},"The First Affiliated Hospital of Zhengzhou University","450052",{"type":50,"coordinates":149},[137,138],{"lat":138,"lon":137},[152],{"name":153,"role":38,"phone":154,"phoneExt":25,"email":155},"Mengying Yao","13592665719","ymy13592665719@163.com",{"facility":157,"status":43,"city":158,"state":159,"zip":160,"country":47,"countryCode":48,"cosmosGeoPoint":161,"geoPoint":165,"contacts":166},"Wuhan Central Hospital","Wuhan","Hubei","430014",{"type":50,"coordinates":162},[163,164],114.26667,30.58333,{"lat":164,"lon":163},[167],{"name":168,"role":38,"phone":169,"phoneExt":25,"email":170},"Jixiang N","13477838399","keamin77@163.com",{"facility":172,"status":43,"city":173,"state":174,"zip":175,"country":47,"countryCode":48,"cosmosGeoPoint":176,"geoPoint":180,"contacts":181},"Xiangtan Central Hospital","Xiangtan","Hunan","411100",{"type":50,"coordinates":177},[178,179],112.9,27.85,{"lat":179,"lon":178},[182],{"name":183,"role":38,"phone":184,"phoneExt":25,"email":185},"Mingyan Jiang","13761128012","jiangmingyan@163.com",{"facility":187,"status":43,"city":188,"state":189,"zip":190,"country":47,"countryCode":48,"cosmosGeoPoint":191,"geoPoint":195,"contacts":196},"The First Affiliated Hospital of Nanchang University","Nanchang","Jiangxi","330006",{"type":50,"coordinates":192},[193,194],115.85306,28.68396,{"lat":194,"lon":193},[197],{"name":198,"role":38,"phone":199,"phoneExt":25,"email":200},"Xin Gan","13576950369","ganxin1207@126.com",{"facility":202,"status":43,"city":203,"state":204,"zip":205,"country":47,"countryCode":48,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Weifang People's Hospital","Weifang","Shandong","261041",{"type":50,"coordinates":207},[208,209],119.10194,36.71,{"lat":209,"lon":208},[212],{"name":213,"role":38,"phone":214,"phoneExt":25,"email":215},"Bo Liu","17660292456","42820159@qq.com",{"facility":217,"status":43,"city":218,"state":219,"zip":220,"country":47,"countryCode":48,"cosmosGeoPoint":221,"geoPoint":225,"contacts":226},"Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital","Chengdu","Sichuan","610072",{"type":50,"coordinates":222},[223,224],104.06667,30.66667,{"lat":224,"lon":223},[227],{"name":228,"role":38,"phone":229,"phoneExt":25,"email":230},"Xiaobo Huang","18981838938","drhuangxb@163.com",{"facility":232,"status":43,"city":233,"state":219,"zip":234,"country":47,"countryCode":48,"cosmosGeoPoint":235,"geoPoint":239,"contacts":240},"Dazhou Central Hospital","Dazhou","635099",{"type":50,"coordinates":236},[237,238],107.46308,31.2106,{"lat":238,"lon":237},[241],{"name":242,"role":38,"phone":243,"phoneExt":25,"email":244},"Pingfei Wang","13079046669","956565257@qq.com",{"facility":246,"status":43,"city":247,"state":248,"zip":249,"country":47,"countryCode":48,"cosmosGeoPoint":250,"geoPoint":254,"contacts":255},"Hangzhou First People's Hospital","Hangzhou","Zhejiang","310006",{"type":50,"coordinates":251},[252,253],120.16142,30.29365,{"lat":253,"lon":252},[256],{"name":257,"role":38,"phone":258,"phoneExt":25,"email":259},"Wei Hu","13750890929","huwei@hospital.westlake.edu.cn",{"type":261,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100608979","phase-3-to-evaluate-the-safety-and-efficacy-of-stsa-1002-injection-in-patients-with-acute-respiratory-distress-syndrome-100608979",false,"NCT07208591","To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome","Phase Ⅲ Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome","Inclusion Criteria:\n\n1. 18 years old ≤ ≤ 85 years old;\n2. laboratory tests results indicate respiratory viral infection;\n3. Fulfills the diagnostic criteria for A New Global Definition of Acute Respiratory Distress Syndrome ;\n4. The time from the onset of respiratory infection-related symptoms to randomization is ≤ 12 days (for patients without invasive mechanical ventilation)\u002F)\u002F≤ 14 days (for patients with invasive mechanical ventilation); Or worsening of respiratory infection-related symptoms within ≤7 days from randomization;\n5. PaO2\u002FFiO2≤200mmHg;\n6. The subjects (including their partners) have no plans to have children during the trial and within 3 months after the last dose, and agree to take appropriate and effective contraceptive measures (such as contraceptive pills, condoms, etc.);\n7. Volunteer to participate in the trial and sign the informed consent form.\n\nExclusion Criteria:\n\n1. ECMO before the first dose;\n2. According to the comprehensive judgment of the investigator, the patient's condition improved within 48 hours before the first dose;\n3. The expected survival period is no more than 24 hours or cardiac arrest occurred 4 weeks before the first dosedose;\n4. Patients with stroke or acute coronary syndrome within 3 months before randomization;\n5. Patients with cardiogenic pulmonary edema, which is the main cause of respiratory failure; New York Heart Classification III-IV patients;\n6. Severe chronic respiratory failure;\n7. Known active pulmonary tuberculosis;\n8. Combined with liver insufficiency\n9. Long-term dialysis and\u002For known severe renal impairment Cytomegalovirus infection;\n10. Known HIV infection with CD4+ T-lymphocyte count \\\u003C 200 cells\u002FμL;\n11. Organ transplant patients;\n12. Patients who received radiotherapy and chemotherapy in the past 1 years or the malignant tumor is still in the active phase;\n13. Septic shock\n14. Absolute neutrophil count is less than 0.5×109\u002FL;\n15. Hemoglobin is less than 60g\u002FL, or the researcher judges that there is active gastrointestinal bleeding;\n16. Severe underlying diseases with poor compliance with basic treatment;17. Pregnant or lactating women;\n\n18\\. Participated in new drug clinical trials and medication within 3 months before screening; 19. Allergic or allergic to any component of the trial drug and its excipients (such as allergic to two or more drugs); 20. Other diseases or conditions that the investigator considers unsuitable for participation in this trial.","ALL","18 Years","85 Years",{"count":273,"type":274},406,"ESTIMATED","INTERVENTIONAL",[277],"PHASE3","To evaluate the efficacy, safety and tolerability of STSA-1002 injection in patients with acute respiratory distress syndrome",[280],"Acute Respiratory Distress Syndrome (ARDS)","2025-12-31",{"date":283,"type":284},"2026-01-02","ACTUAL",{"date":286,"type":284},"2025-10-31",{"date":288,"type":274},"2026-10",{"name":5,"class":6},15]